185 related articles for article (PubMed ID: 2117855)
21. Reliable co-segregation analysis for prenatal diagnosis and heterozygote detection in Gaucher disease.
Cormand B; Montfort M; Chabás A; Grinberg D; Vilageliu LL
Prenat Diagn; 1998 Mar; 18(3):207-12. PubMed ID: 9556036
[TBL] [Abstract][Full Text] [Related]
22. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
23. Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients.
Amaral O; Marcão A; Sá Miranda M; Desnick RJ; Grace ME
Eur J Hum Genet; 2000 Feb; 8(2):95-102. PubMed ID: 10757640
[TBL] [Abstract][Full Text] [Related]
24. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations.
Drugan C; Procopciuc L; Jebeleanu G; Grigorescu-Sido P; Dussau J; Poenaru L; Caillaud C
Eur J Hum Genet; 2002 Sep; 10(9):511-5. PubMed ID: 12173027
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
Torralba MA; Pérez-Calvo JI; Pastores GM; Cenarro A; Giraldo P; Pocoví M
Blood Cells Mol Dis; 2001; 27(2):489-95. PubMed ID: 11259172
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
[TBL] [Abstract][Full Text] [Related]
27. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
Choy FY; Bouillon L; Laurin CA
Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
[TBL] [Abstract][Full Text] [Related]
28. Linkage disequilibrium of common Gaucher disease mutations with a polymorphic site in the pyruvate kinase (PKLR) gene.
Rockah R; Narinsky R; Frydman M; Cohen IJ; Zaizov R; Weizman A; Frisch A
Am J Med Genet; 1998 Jul; 78(3):233-6. PubMed ID: 9677056
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype.
Beutler E; West C
Isr Med Assoc J; 2002 Nov; 4(11):986-8. PubMed ID: 12489486
[TBL] [Abstract][Full Text] [Related]
30. Type 2 Gaucher disease occurs in Ashkenazi Jews but is surprisingly rare.
Aviner S; Garty BZ; Rachmel A; Baris HN; Sidransky E; Shuffer A; Attias J; Yaniv Y; Cohen IJ
Blood Cells Mol Dis; 2009; 43(3):294-7. PubMed ID: 19734074
[TBL] [Abstract][Full Text] [Related]
31. DNA mutation analysis of Gaucher patients.
Sidransky E; Tsuji S; Martin BM; Stubblefield B; Ginns EI
Am J Med Genet; 1992 Feb; 42(3):331-6. PubMed ID: 1536173
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients.
Horowitz M; Tzuri G; Eyal N; Berebi A; Kolodny EH; Brady RO; Barton NW; Abrahamov A; Zimran A
Am J Hum Genet; 1993 Oct; 53(4):921-30. PubMed ID: 8213821
[TBL] [Abstract][Full Text] [Related]
33. Complex alleles of the acid beta-glucosidase gene in Gaucher disease.
Latham T; Grabowski GA; Theophilus BD; Smith FI
Am J Hum Genet; 1990 Jul; 47(1):79-86. PubMed ID: 2349952
[TBL] [Abstract][Full Text] [Related]
34. Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease.
Seeman PJ; Finckh U; Höppner J; Lakner V; Liebisch I; Grau G; Rolfs A
Neurology; 1996 Apr; 46(4):1102-7. PubMed ID: 8780099
[TBL] [Abstract][Full Text] [Related]
35. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
Grace ME; Graves PN; Smith FI; Grabowski GA
J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
[TBL] [Abstract][Full Text] [Related]
36. An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H.
Bronstein S; Karpati M; Peleg L
Isr Med Assoc J; 2014 Nov; 16(11):683-5. PubMed ID: 25558695
[TBL] [Abstract][Full Text] [Related]
37. Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient.
Graves PN; Grabowski GA; Eisner R; Palese P; Smith FI
DNA; 1988 Oct; 7(8):521-8. PubMed ID: 3180993
[TBL] [Abstract][Full Text] [Related]
38. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.
Tsuji S; Martin BM; Barranger JA; Stubblefield BK; LaMarca ME; Ginns EI
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2349-52. PubMed ID: 3353383
[TBL] [Abstract][Full Text] [Related]
39. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
[TBL] [Abstract][Full Text] [Related]
40. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.
Beutler E; Gelbart T; Kuhl W; Sorge J; West C
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10544-7. PubMed ID: 1961718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
